ArticleNaunyn-Schmiedeberg's archives of pharmacology2019

Growth inhibitor of human hepatic carcinoma HepG2 cells by evodiamine is associated with downregulation of PRAME.

Hanzhang Zhu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.